囊病的治疗策略:聚焦囊胺和其它方面
Angelo Santoro1, Yuri Vincenzo Ferrara2, Alfonso De Angelis2
1Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy; Department of Pharmacy, Scuola di Specializzazione in Farmacia Ospedaliera, University of Salerno, 84084, Italy.
这是一种遗传性疾病, 导致囊积聚, 损害器官. 目前的治疗方法如囊胺有助于治疗这种罕见疾病,
科学领域:
- 遗传学和罕见疾病
- 溶解体储存障碍
- 分子医学
背景情况:
- 囊症是一种自体递归的溶酶体储存疾病.
- 由CTNS基因突变引起,导致囊积累和多器官损伤.
- 在婴儿期出现性囊病,随着性芬科尼综合征的进展,导致功能衰竭.
研究的目的:
- 审查目前和新的治疗策略.
- 讨论基于囊胺的疗法的有效性和局限性.
- 探索新兴疗法以改善患者的治疗结果.
主要方法:
- 对囊病治疗的现有文献的审查.
- 对囊胺疗法的疗效和副作用的分析
- 探索包括基因疗法和小分子在内的新疗法.
主要成果:
- 囊胺治疗降低了囊的水平,并减缓了疾病的进展.
- 终身治疗有局限性,包括副作用和剂量频率.
- 移植是末期病的一个选择, 但外问题仍然存在.
结论:
- 目前的治疗方法有所改善,
- 基因疗法和向性降解等新的策略显示出有前途.
- 多学科管理和持续的研究对于提高生活质量至关重要.
更多相关视频
15:12Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
